Pediatric Puzzler: Lymphadenopathy and nosebleeds in 2-year-old girl: Is anything as it seems?

Article

A 2-1/2-year-old girl's adenopathy has not subsided five days after initiation of antibiotic therapy with amoxicillin and clavulanate potassium (Augmentin). And lately, she seems to be having "a lot" of nosebleeds.

Recent Videos
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Contemporary Pediatrics: RX Review: Updates and Unmet Need in RSV thumbnail
Staphylococcus aureus risk in infants and neonatologist considerations with Aaron Milstone, MD
How fragrance plays a role in atopic dermatitis treatments, with John Browning, MD
Octavio Ramilo, MD, reacts to the FDA approval of clesrovimab for RSV prevention | Image Credit: St. Jude Children's Research Hospital
Related Content
A headache with a red flag in a 10-year-old girl

A headache with a red flag in a 10-year-old girl

Sheanda Thambyrajah, MD;Rachel Hansen;Bridget Boyd, MD, FAAP
June 18th 2025
Article

The patient described the headache as “pressure-like,” episodes that occurred for 1 to 2 hours with high severity.

Site Logo

Food Insecurity and the Dangers of Infant Formula Dilution

January 30th 2023
Podcast
LLS

Olivia is helping patients and families understand the experience of blood cancer

The Leukemia & Lymphoma Society
June 18th 2025
Article
Demystifying Infant Formula

Demystifying Infant Formula

October 11th 2022
Podcast
AAP issues updated guidance on contraception for adolescents | Image Credit: © New Africa - stock.adobe.com.

AAP updates guidance on contraception for adolescents

Morgan Ebert, Managing Editor
June 18th 2025
Article

The American Academy of Pediatrics urges clinicians to offer confidential, adolescent-centered contraceptive care using evidence-based, equity-informed approaches.

FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions | Image credit: Contemporary Pediatrics

FDA accepts NDA for epinephrine sublingual film to treat type 1 allergic reactions

Joshua Fitch, Senior Editor
June 17th 2025
Article

The federal agency has assigned a target action date of January 31, 2026, for a decision.

© 2025 MJH Life Sciences

All rights reserved.